Engineered clearing agents for the selective depletion of antigen-specific antibodies

被引:31
|
作者
Devanaboyina, Siva Charan [1 ,2 ]
Khare, Priyanka [1 ,2 ]
Challa, Dilip K. [1 ,2 ]
Ober, Raimund J. [1 ,3 ]
Ward, E. Sally [1 ,2 ]
机构
[1] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, 469 Joe H Reynolds Med Sci Bldg,1114 TAMU, College Stn, TX 77843 USA
[2] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, 3107 Med Res & Educ Bldg,8447 State Highway 47, Bryan, TX 77807 USA
[3] Texas A&M Univ, Dept Biomed Engn, 5045 Emerging Technol Bldg,3120 TAMU, College Stn, TX 77843 USA
来源
NATURE COMMUNICATIONS | 2017年 / 8卷
关键词
MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEONATAL FC-RECEPTOR; I-RELATED RECEPTOR; MULTIPLE-SCLEROSIS; NONHUMAN-PRIMATES; IGG; AUTOIMMUNE; REDUCTION; BLOCKADE; DELIVERY;
D O I
10.1038/ncomms15314
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Here we have designed a novel class of engineered antibody-based reagents ('Seldegs') that induce the selective degradation of antigen-specific antibodies. We demonstrate the rapid and specific clearance of antibodies recognizing the autoantigen, myelin oligodendrocyte glycoprotein and tumour target, HER2. Seldegs have considerable potential in multiple areas, including the treatment of antibody-mediated autoimmunity and diagnostic imaging.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Engineered clearing agents for the selective depletion of antigen-specific antibodies
    Siva Charan Devanaboyina
    Priyanka Khare
    Dilip K. Challa
    Raimund J. Ober
    E. Sally Ward
    Nature Communications, 8
  • [2] Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease
    Sun, Wei
    Khare, Priyanka
    Wang, Xiaoli
    Challa, Dilip K.
    Greenberg, Benjamin M.
    Ober, Raimund J.
    Ward, E. Sally
    MOLECULAR THERAPY, 2021, 29 (03) : 1312 - 1323
  • [3] Antigen-specific agents in development
    Sznol, M
    Holmlund, J
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : 173 - 186
  • [4] Nanoparticles engineered for antigen-specific immunotherapy
    Alexandra Flemming
    Nature Reviews Immunology, 2016, 16 : 205 - 205
  • [5] Nanoparticles engineered for antigen-specific immunotherapy
    Alexandra Flemming
    Nature Reviews Drug Discovery, 2016, 15 : 233 - 233
  • [6] Nanoparticles engineered for antigen-specific immunotherapy
    Flemming, Alexandra
    NATURE REVIEWS IMMUNOLOGY, 2016, 16 (04) : 205 - 205
  • [7] DEPLETION OF ANTIGEN-SPECIFIC LYMPHOCYTE CLONES INVIVO
    HAY, JB
    CAHILL, RNP
    TRNKA, Z
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 646 - 646
  • [8] Microscale purification of antigen-specific antibodies
    Brown, Eric P.
    Normandin, Erica
    Osei-Owusu, Nana Yaw
    Mahan, Alison E.
    Chan, Ying N.
    Lai, Jennifer I.
    Vaccari, Monica
    Rao, Mangala
    Franchini, Genoveffa
    Alter, Galit
    Ackerman, Margaret E.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2015, 425 : 27 - 36
  • [9] AUTOIMMUNITY Nanoparticles engineered for antigen-specific immunotherapy
    Flemming, Alexandra
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) : 233 - 233
  • [10] SELECTIVE EXPANSION OF ANTIGEN-SPECIFIC CD8 T CELLS WITH ENGINEERED ANTIGEN PRESENTING EXOSOME
    Yamano, Tomoyoshi
    Lyu, Xiabing
    Hanayama, Rikinari
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A743 - A743